Stay up to date on the latest oncology and nursing conferences.
Preoperative Treatment with Atezolizumab/Epirubicin Plus Trastuzumab/Pertuzumab Elicits High pCR Rate in Patients With Early HER2+ Positive Breast Cancer
Patients with early-stage HER2-positive breast cancer experienced a high rate of pathologic complete response with combined preoperative treatment with atezolizumab, epirubicin, trastuzumab, and pertuzumab.
Patients With De Novo or Late Recurrent Metastatic HR+ Breast Cancer Derive OS Benefit From Ribociclib/Letrozole
A subgroup analysis showed that patients with hormone receptor–positive, HER2-negative advanced breast cancer who had de novo metastatic disease or late recurrence from neoadjuvant therapy achieved better outcomes with ribociclib plus letrozole.
Kellie Zeichner Speaks to the Power of Standardized Monitoring Procedures for Patients With Rare Tumors
Kellie Zeichner BSN, RN, OCN, explains how her institution created a standardized monitoring procedure for insulinoma care.
Brenda Martone Highlights Nursing Considerations With Darolutamide in Prostate Cancer
Brenda Martone MSN, ANP-BC, AOCNP, discusses what nurses need to know about safely treating patients with darolutamide.
Olaparib Delivers PFS Benefit to Patients with gBRCA+, HER2– Metastatic Breast Cancer, Independent of ER Status
A post-hoc analysis suggests that olaparib may extend progression-free survival in patients with germline BRCA-mutated, HER2-negative metastatic breast cancer, no matter their estrogen receptor expression level.
Kara Morris and Christine Wylie on Oral Cryotherapy for Chemotherapy-Induced Mucositis in Breast Cancer
Kara Morris, MSN, RN, OCN; and Christine Wylie, MSN, RN, OCN, discuss the benefits of oral cryotherapy for patients receiving dose-dense doxorubicin.
Trastuzumab Deruxtecan Exhibits Favorable Safety Profile in DESTINY-Breast04 Follow-Up
Trastuzumab deruxtecan outperformed investigators choice of therapy, in terms of safety, among patients with HER2-Low Metastatic Breast Cancer.
Neutropenia and Diarrhea AEs Did Not Impact Clinical Outcomes for Patients with mTNBC Receiving Sacituzumab Govitecan
Using established guidelines to monitor and intervene early for diarrhea and neutropenia may result in longer treatment durations and sustained benefit from sacituzumab govitecan.
Melanie Darvish on Receiving an ONS Scholarship and What it Means to Be An Oncology Nurse
Melanie Darvish, BSN, RN, shares her experience attending the Oncology Nursing Society (ONS) Congress with an ONS Scholarship.
Heath-related QOL Maintained Longer With Trastuzumab Deruxtecan in HER2+ mBC
The time to definitive deterioration was delayed among patients receiving trastuzumab deruxtecan vs treatment of physician’s choice in all prespecified scales in DESTINY-Breast02.
Abemaciclib Displays Manageable and Reversible Safety Profile in monarchE PRO Findings for HR+/HER2– Breast Cancer
Patient-reported outcomes demonstrated a manageable safety profile with abemaciclib.
AnnMarie Walton on Reducing Antineoplastic Drug Residue in Inpatient Units
AnnMarie Walton, PhD, MPH, RN, OCN, CHES, FAAN, discusses her research on plastic-backed pads and discusses the importance of better methods to reduce exposure to antineoplastic drug residue.
Enzalutamide Associated With Lower Metastases Risk Vs Leuprolide Alone in High-Risk nmHSPC
Enzalutamide plus leuprolide lowered the risk of metastases or death by 58% compared with placebo plus leuprolide.
Apalutamide/ADT Shows PFS Improvement in Relapsed Prostate Cancer
Apalutamide plus androgen deprivation therapy (ADT) yielded a progression-free survival of 24.5 months vs 21.0 months with ADT alone.
Low and Maldonado on Leveraging Wearable Devices to Improve Inpatient Ambulation
Sarah Low RN, MSN, OCN, CMSRN; and Claudia Maldonado-Howell, RN, MSN, FNP, BS, CMSRN, discuss their research on wearable technology.
Heather Niccum Haag on Improving Patient Education With Belzutifan
Heather Niccum Haag, BSN, RN, CCRN, shares her experience creating an educational resource for her patients with Von-Hippel Lindau tumors who are receiving belzutifan.
Bisphosphonates May Reduce Fracture Risk in Patients With Metastatic Hormone-Sensitive Prostate Cancer
A database analysis showed that zoledronic acid led to a 64% reduction in fracture risk among patients with metastatic hormone-sensitive prostate cancer.
Nivolumab Following Radical Surgery Extends Disease-Free Survival Rates in Bladder Cancer
Nivolumab bested placebo in improving disease-free survival rates in patients with muscle-invasive urothelial carcinoma and muscle-invasive bladder cancer.
Gene Therapy Agent URO-902 Shows Promise in Helping Woman Manage Overactive Bladder and Urinary Incontinence
Phase 2a trial data suggest that single-dose URO-902 may be an effective, and safe, treatment for women experiencing difficulties with bladder control.
Elizabeth Loach on Integrating Frontline Staff in Nursing Task Forces
Elizabeth Loach, MSN, APRN, CNS, AGCNS-BC, OCN, discusses the importance of including frontline nurses in nursing leadership task forces.
Splashblocker Shows Promise in Reducing Spread of Hospital Toilet Contaminants
The Splashblocker was found to be an effective way to reduce contaminated particles. Plastic backed pads had mixed reviews.
Apalutamide Elicits PSA Response, Lowers Progression to Castration Resistant Disease in mCSPC
Findings from a real-world, retrospective analysis support the use of apalutamide for the prostate-specific antigen reduction among patients with metastatic castration-sensitive prostate cancer.
Nurse Investigators on Using Weighted Blankets to Alleviate Anxiety During Cancer Treatment Infusions
Oncology nurse investigators from Dana-Farber discuss the value of weighted blankets in reducing patient anxiety during infusions.
Best Practices on Managing AEs With Darolutamide Plus ADT/Docetaxel in mHPSC
Data presented during the ONS Annual Congress offers guidance for nurses caring for patients receiving darolutamide, docetaxel, and androgen deprivation therapy.
Jessica MacIntyre on Improving LLS Referrals For Patients With Hematologic Malignancies
Jessica MacIntyre, DNP, MBA, APRN, NP-C, AOCNP, discusses ways to standardize the process of referring patients to the Leukemia and Lymphoma Society.
Cardiac Event Management Is a Key Aspect of Safely Treating Patients With Ribociclib in Advanced Breast Cancer
Rita Deimler, MSN, ANP-BC, outlines best cardiac event monitoring and management practices for patients receiving the CDK4/6 inhibitor ribociclib.
Recognizing Maladaptive Coping and Building Resilience in Oncology Nursing Is Vital
Acknowledging and addressing maladaptive coping mechanisms may help reduce moral distress and burnout among oncology nurses.
Stephanie Jackson on Improving the Double Verification Process For High-Alert Medications
Stephanie Jackson, DNP, MSN, RN, AOCNS, BMTCN, highlights how her unit leveraged an educational video to improve compliance with double verification for high-alert medications.
Eric Zack on Disseminated Intravascular Coagulation Prevention and Management
Eric Zack, DNP, RN, ACNP-BC, AOCN, BMTCN, describes disseminated intravascular coagulation and best nursing strategies to mitigate the severity of this condition.
Avasopasem Manganese Significantly Reduces IMRT-Induced Severe Oral Mucositis, Is Feasible in Clinical Workflow
Elizabeth R. Cullen, MSN, ARNP, highlights the efficacy of avasopasem manganese in mitigating severe oral mucositis in patients with locally advanced head and neck cancer.
Olanzapine Significantly Reduces CINV in Patients Receiving MEC
Reimagining Frailty Screenings in Head and Neck Cancer
Screening for Pain and Depression is Not Enough in Cancer Care
Niraparib-Based Triplet Therapy Offers OS Advantage in BRCA1/2+ mCRPC
2 Clarke Drive Cranbury, NJ 08512